Product Detail  

  Product Detail  

1. AU100 AHK-Cu 100mg Product Description

   1. Product Overview

   AU100 is a product specification commonly associated with AHK-Cu, also known as Alanyl-Histidyl-Lysine Copper. The available specification is 100 mg per vial (100 mg/vial). AHK-Cu is a synthetic peptide-copper complex supplied for laboratory and research-related applications.

   This product description is intended to provide general product and specification information only. It does not provide information regarding human use, animal use, diagnosis, treatment, prevention of disease, dosage, or administration.

   The actual product name, composition, purity, CAS number, molecular formula, molecular weight, packaging, and other technical parameters should always be confirmed against the applicable batch-specific COA, SDS, TDS, product label, and other supporting documentation.

   2. Basic Product Information

   • Product Name: AU100 / AHK-Cu
   • Product Specification: 100 mg/vial
   • Product Form: Lyophilized powder
   • Product Category: Peptide-related research material
   • Common English Name: AHK-Cu / Alanyl-Histidyl-Lysine Copper
   • Model: AU100
   • Brand: According to the actual product label
   • Purity: According to the applicable batch COA
   • CAS No.: According to the applicable technical documentation
   • Molecular Formula: According to the applicable technical documentation
   • Molecular Weight: According to the applicable technical documentation
   • Packaging: According to the actual supply specification

   Product parameters should not be supplemented with unverified information. Where a technical parameter is not supported by the applicable product documentation, it is recommended to leave the field blank or indicate that the value is subject to the batch-specific documentation.

   3. Appearance

   AU100 is commonly supplied as a lyophilized powder. The actual appearance may vary slightly between batches depending on manufacturing and storage conditions.

   For accurate product presentation, the appearance should be described according to the actual product and corresponding quality documentation.

   Recommended description:

   “Lyophilized powder; appearance subject to the actual batch and applicable quality documentation.”

   Statements such as “100% pure white,” “zero impurities,” or other absolute quality claims should not be used unless they are directly supported by appropriate testing documentation.

   4. Specification

   The primary specification of AU100 is 100 mg/vial.

   The actual packaging configuration may vary according to the supplier and order requirements. For example, products may be supplied as individual vials or as multiple-vial packages.

   The product page should clearly distinguish between:

   • Net content per vial;
   • Number of vials per package;
   • Total package quantity;
   • Batch number;
   • Manufacturing information;
   • Corresponding COA information.

   Packaging information should always match the actual goods supplied.

   5. Quality Information

   Product quality should be described based on actual batch-specific testing data.

   Depending on the available documentation, quality information may include:

   • Appearance;
   • Purity;
   • HPLC analysis;
   • Mass spectrometry;
   • Molecular weight confirmation;
   • Moisture or other applicable parameters;
   • Batch number;
   • Testing date;
   • Testing organization.

   If a specific purity value is listed, it should be supported by the corresponding COA or analytical report.

   Unsupported claims such as “99.9% purity,” “pharmaceutical grade,” “sterile,” “endotoxin-free,” or similar statements should not be included unless they are verified by appropriate documentation.

   Different suppliers and batches may have different specifications and analytical results. Therefore, third-party test results should not be presented as the quality specifications of the current product.

   6. Intended Application

   AU100 / AHK-Cu may be supplied as a research material for laboratory and scientific research applications.

   The product description is limited to general research-related information and does not provide instructions for human or animal administration.

   No dosage, administration route, therapeutic recommendation, disease-related claim, or medical efficacy statement is provided in this product description.

   Where a specific application is stated, it should correspond to the actual product documentation, legitimate intended use, and applicable regulatory requirements.

   7. Storage

   Storage conditions should be determined according to the actual product label, COA, SDS, TDS, or other applicable technical documentation.

   Recommended general wording:

   “Store and handle according to the product label, SDS, COA, and applicable technical documentation. Specific storage conditions are subject to the requirements for the actual batch.”

   The supplier should not state a specific storage temperature or shelf life unless the information is supported by the applicable product documentation.

   8. Packaging

   AU100 may be supplied in sealed vials or other suitable packaging depending on the actual product specification.

   The packaging should provide appropriate product identification and relevant batch information.

   The following information should be consistent with the actual shipment:

   • Product name;
   • Product specification;
   • Net content;
   • Batch number;
   • Packaging quantity;
   • Storage information;
   • Other applicable labeling information.

   If special transportation or storage requirements apply, the product should be handled in accordance with the applicable SDS and transportation requirements.

   9. Documentation

   For procurement and compliance review, the following documents may be provided where available and applicable:

   • Certificate of Analysis (COA);
   • Safety Data Sheet (SDS);
   • Technical Data Sheet (TDS);
   • Product specification sheet;
   • Batch analytical report;
   • Product label;
   • Other legally required certificates or supporting documents.

   All documents should correspond to the actual product and, where applicable, the relevant production batch.

   If a required certificate or qualification has not been obtained or uploaded, it should not be represented as available or complete.

   10. Compliance Statement

   This product information is provided for product identification, specification reference, quality documentation, and legitimate procurement purposes.

   The regulatory classification, transportation requirements, import requirements, and sales conditions applicable to AU100 may vary depending on the actual composition, intended application, destination country or region, and applicable laws and regulations.

   Where the product is subject to hazardous chemical regulations or other controlled-material requirements, the relevant qualifications and documentation should be confirmed before conducting the applicable business activities.

   Product information should accurately reflect the actual goods and supporting documentation. Product names, specifications, purity, applications, and regulatory information should not be altered or presented inaccurately for the purpose of bypassing platform review.

   11. Recommended Product Page Information

   For an accurate and consistent ECHEMI product listing, the following information can be used where supported by the actual documentation:

   Product Name: AU100 AHK-Cu
   Specification: 100 mg/vial
   Appearance: Lyophilized powder, subject to actual batch
   Application: Laboratory research use, subject to legitimate intended use
   Purity: According to batch-specific COA
   CAS No.: According to applicable technical documentation
   Packaging: According to actual packaging
   Storage: According to SDS, COA, TDS, and product label
   Quality Documents: Available documents applicable to the actual product

   12. Final Note

   AU100 / AHK-Cu should be described using accurate and verifiable product information. Technical parameters such as CAS number, purity, molecular weight, composition, and regulatory classification should not be added without supporting documentation.

   Before publishing the product on ECHEMI, suppliers should ensure that the product identity, specifications, quality documents, labeling, intended application, and required qualifications are consistent with the actual product and applicable regulations.

   The final product information should be based on the actual product label, COA, SDS, TDS, analytical reports, qualification documents, and applicable laws and regulations.